NCT00070382
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +55 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
Clinical trial condition
Multiple Myeloma and Plasma Cell Neoplasm
Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.
214 public trials
4 recruiting studies
Multiple Myeloma and Plasma Cell Neoplasm trial results
NCT00068523
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00054236
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +75 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00750009
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT00941720
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT00006890
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
- Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
NCT00002678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
NCT00053989
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +67 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00568880
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States